Company / Capital Returned to Shareholders
United Therapeutics Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$1.0B
FY2025
5-year range
$0 / $1.0B
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#11 of 52
Health Care
What the data says
United Therapeutics's capital returned to shareholders of $1.0B is higher than 79% of companies in the Health Care sector (FY2025). Improved from $0 to $1.0B over the past 2 years.
Based on SEC 10-K filings.
$1.0B in FY2025. Top quartile in the Health Care sector.
Improved from $0 to $1.0B over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 52This company $1.0B Sector average $1.3B
▼
-25.1% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 0.0% year-over-year.
- Ranks #11 out of 52 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +0.0% |
| FY2024 | $1.0B | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $394.5M | -21.1% |
| FY2016 | $500.0M | +26.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026